A federal judge in New Jersey yesterday transferred a sales rep poaching case between DJO Global and Stryker (NYSE:SYK) to Indiana because the quintet of ex-Stryker sales reps involved live there and most of the events in th case occurred in the Hoosier State.
The lawsuit, originally filed in April 2016 in the U.S. District Court for New Jersey, alleged a scheme by DJO and the former Stryker sales reps – Kywin Supernaw, Brad Bolinger, Justin Davis, Jake Eisterhold, Eric Huebner and Tim Broecker – that took a roughly 33% bite out of Stryker’s ortho & trauma sales in Indiana in 2015.
In June 2016 DJO and the reps fired back, asking Judge John Michael Vazquez to dismiss the case for lack of evidence, or alternatively to shift it to the U.S. District Court for Southern Indiana. Yesterday Vazquez granted the motions to relocate the case, according to court documents.
Image Credit: MassDevice
The Silicon chip and the stethoscope have long gone hand in hand. Indeed, Moore’s Law, a widely used forecast of rising computing power, can often seem to be nudging healthcare into the realm of science fiction, with life-saving high-tech innovations coming at a rapid rate today — and plenty more in the pipeline. That is surely good news for investors, and not only those with a medical focus.
“The potential for growth extends beyond the traditional healthcare sector,” says Sarbjit Nahal, head of Thematic Investing at BofA Merrill Lynch Global Research. With the provision that rising chip speeds can render a promising technology obsolete all too quickly (DVD, say hello to cloud streaming), here are the top five innovations Nahal and fellow “futurologist” Joseph Quinlan, head of Market & Thematic Strategy at U.S. Trust, think may offer investment opportunities in the years ahead.
Illustration Credit: Merrill Lynch
For many, the advantages of becoming an independent far outweigh the disadvantages. Unlike an employee who works for an employer, independent reps, independent contractors or independent consultants often work for a number of different clients, companies and / or product lines that require their special expertise and established relationships. Independent sales reps and independent consultants are self-employed entrepreneurs and most are very GOOD at what they do or they couldn’t be independent, without that comfort zone of a base salary. Independent agents must be self starters, highly motivated, good at marketing yourself, marketing YOUR business, AND excellent at closing !
Twelve (12) advantages of being self-employed as an independent contractor:
- As an independent, you are your own boss.
- Income Earnings for Independent Sales Reps and Distributors are typically paid a higher compensation for actual results than one would receive as an employee. Make sure you leverage your power of already having established relationships and/or the expertise you have. (Compensation for: who you know and what you know!)
- Independent contractors have the ability to set and negotiate their own price or fee schedule. Consultants need to understand How to calculate consulting fees when setting up your consulting business.
The market for medical devices historically has been dominated by big-ticket “physician preference items” such as artificial joints, spinal implants, and cardiac pacemakers. Venture capital and private equity investors have been eager to fund new firms in this expanding and lucrative domain. Changes in physician payment and organization are reducing the demand for these cost-increasing innovations, however, and redirecting the flow of investment capital.
For the past decade we have been studying medical device innovation (startup firms) and adoption (hospital organizations), starting from different angles but arriving at similar conclusions. Josh is a venture capitalist affiliated with Sightline Partners and Split Rock Partners, with an investment focus on medical devices, instruments, and diagnostic tests. James is a university economist with a research focus on payment methods and how these influence the adoption of high-cost technologies. We decided to put our perspectives together and look at both ends of the innovation and adoption process.
All your Motley Fool coverage of the JP Morgan Healthcare Conference in one place.
The annual J.P. Morgan Healthcare Conference, often called the Superbowl of biotech, kicked off on January 9, 2017.
The Motley Fool has you covered with reports on company presentations and themes from the conference. Check back daily for updates!
By Kristine Harjes | The Motley Fool
This was yet another year filled with mergers and acquisitions in the medical device industry, with several mega-deals valued well over $1 billion. Many of these transactions are rearranging the order of top players in various device sectors or entirely remaking a technology field. In addition to some of these evolutions, a couple of transactions haven’t moved forward as expected. All of this has added up to exciting and fast-paced changes in the medtech industry.
By Marie Thibault | MD&DI
Worldwide hip and knee orthopedic surgical implant markets are poised to achieve significant growth with the aging of the population.
Older people have trouble making their joints last as long as they do. The patient stability and the relief from pain provided by the implant is compelling. The major suppliers are providing implants that are state of the art. Orthopedic reconstructive implants are used to replace joints that have deteriorated. Deterioration may come as a result of aging, disease, osteoarthritis, or injury.
Total hip replacement surgery has evolved dramatically over the years as advances in technology have made it possible to improve surgical techniques. 325,000 people had total hip replacement surgery in 2015 in the United States. Computer-assisted total hip replacement surgery is one of the latest revolutions in total hip replacement.